Loading
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Latest filing published 11 Sept 2026 for International Stem Cell CORP, €10k.
Insider track record
Disclosed buys
0
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
No signal scores available.
Maier Paul V: trading record in brief
This profile gathers the share dealings of Maier Paul V across 2 companies, led by Eton Pharmaceuticals, Inc. and International Stem Cell Corp. Between 28 August 2026 and 11 September 2026, the trades on record add up to 2 filings.
No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.
The latest filing, published on 11 September 2026, reports a transaction of €10k in International Stem Cell Corp. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Maier Paul V
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations2 total
32,802 shares@ US$0.36CommonSEC144:0001949846-26-000580
50,000 shares@ US$59.07060.17% mcap48.4% of flowCommonSEC144:0001974078-26-000335
2 of 2 declarations
